The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection

NCT04766931 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

DRUG: FB2001
DRUG: FB2001 Placebo

Sponsor

Frontier Biotechnologies Inc.